Dimension Therapeutics - Ownership and Business Overview

Life ScienceCompany

Dimension Therapeutics Ownership

Who owns Dimension Therapeutics?

Dimension Therapeutics is owned by Ultragenyx Pharmaceutical. It was acquired on October 3, 2017.

Was Dimension Therapeutics formerly PE-backed?

Yes. Dimension Therapeutics was formerly owned by 1 private investor.

Dimension Therapeutics Business Overview

Where is Dimension Therapeutics headquartered?

Dimension Therapeutics is headquartered in Cambridge, Massachusetts.

What is Dimension Therapeutics’ revenue?

Dimension Therapeutics disclosed revenue of 11M USD for 2016 and 8M USD for 2015.

How many employees does Dimension Therapeutics have?

Dimension Therapeutics has 74 employees.

What sector is Dimension Therapeutics in?

Dimension Therapeutics is a life science company.

When was Dimension Therapeutics founded?

Dimension Therapeutics was founded in 2013.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 226 by strategics.

Dimension Therapeutics

Dimension Therapeutics, Inc.

840 Memorial Drive, 4th Floor,
Cambridge, Massachusetts 02139
United States,
(617) 401-0011
www.dimensiontx.com

Dimension Therapeutics is a developer of new therapeutic products for people living with devastating rare and metabolic diseases associated with the liver, based on the most advanced mammalian adeno-associated virus (AAV) gene delivery technology. Dimension Therapeutics was founded in 2013 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.